YASMIN GONZALEZ: Open Payments
NPI 1639951254 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,714 in 133 payments from 20 companies in 2025. Trend: 2023 $89 · 2024 $1,416 · 2025 $2,714
Food & beverage: $2,714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $403 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $334 |
| Madrigal Pharmaceuticals | 11 | $311 |
| Aimmune Therapeutics, Inc. | 16 | $272 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $260 |
| Phathom Pharmaceuticals, Inc. | 3 | $183 |
| PFIZER INC. | 10 | $154 |
| Lilly USA, LLC | 7 | $121 |
| Novo Nordisk Inc | 4 | $103 |
| Janssen Biotech, Inc. | 5 | $92 |
Products named: REZDIFFRA, ZENPEP, XIFAXAN, ENTYVIO, VOQUEZNA, SKYRIZI, TREMFYA, DUPIXENT.
Industry payments across FL — which companies pay providers there.
